Archives
-
RSL3, GPX4, and the Translational Ferroptosis Gap
2026-10-03
RSL3 is a widely used glutathione peroxidase 4 inhibitor for studying ferroptosis, but its translational value depends on connecting chemical perturbation with disease biology, biomarker strategy, and orthogonal validation. Integrating supplier-described properties with the Ren et al. hepatocellular carcinoma study, this article examines how TEAD2, redox stress, lipid peroxidation, and tumor context can shape a more rigorous research narrative.
-
EZ Cap Cy5 Firefly Luciferase mRNA Guide
2026-10-02
This scenario-based guide explains how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, separates mRNA uptake from translation in viability, proliferation, cytotoxicity, and delivery studies. It covers assay design, LNP compatibility, handling, data interpretation, and practical vendor-selection criteria.
-
CTDNEP1–NEP1R1 Control of ER Lipid Fate
2026-10-01
Carrasquillo Rodríguez and colleagues show that NEP1R1 stabilizes CTDNEP1 and is required for limiting ER expansion, whereas CTDNEP1 can restrict lipid droplet biogenesis without this regulatory subunit. The study combines cell biology, protein biochemistry, structure–function analysis, and computational modeling to reveal pathway-specific control of lipid synthesis.
-
Hydrocortisone Butyrate: Designing Better Assays
2026-10-01
Hydrocortisone butyrate research is shaped by receptor pharmacology, exposure history, and chemical stability. This guide translates PLGA delivery findings into practical decisions for dermatitis cell models, cutaneous inflammation research, and epidermal physiology assays.
-
Cy5-UTP for Direct RNA Fluorescence
2026-09-30
Cy5-UTP, also called Cyanine 5-uridine triphosphate, is a fluorescent UTP analog for T7-driven in vitro transcription RNA labeling. It enables direct visualization of labeled RNA with reported excitation and emission maxima of 650 and 670 nm, respectively.
-
Nicotine Signaling and Chronic Kidney Disease Progression
2026-09-30
Jain and Jaimes synthesize clinical and experimental evidence that nicotine may accelerate chronic kidney disease through non-neuronal nicotinic acetylcholine receptors, reactive oxygen species, and profibrotic signaling. The review’s main practical value is its separation of nicotine-specific renal mechanisms from the broader toxicology of cigarette smoke, guiding receptor, redox, hemodynamic, and fibrosis-focused study design.
-
AO/PI Double Staining Kit: Practical Guide
2026-09-29
The AO/PI Double Staining Kit provides a rapid fluorescent cell viability assay that separates viable, apoptotic, and membrane-compromised cells using Acridine Orange and Propidium Iodide. It is suitable for comparative screening and qualitative cell-death assessment, but staining patterns should be validated with appropriate controls and should not be treated as a standalone proof of a specific death pathway.
-
URB597: Causal Mapping of FAAH Signaling
2026-09-29
URB597 (KDS-4103) is a selective FAAH inhibitor for testing how anandamide metabolism shapes endocannabinoid signaling. This article presents a causal, assay-centered framework that separates FAAH-dependent mechanisms from the broader pharmacology of cannabidiol in pain and neuroinflammation research.
-
NADH Reprograms E. tarda Antibiotic Killing
2026-09-28
A 2024 Virulence study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism, increase ATP availability, and strengthen the bactericidal activity of neomycin. The work supports metabolic supplementation as an antibiotic-adjuvant strategy while identifying important limits for translation beyond bacterial culture systems.
-
Vincristine Sulfate: From Tubulin to Translation
2026-09-28
Vincristine sulfate offers translational researchers a defined way to perturb microtubule dynamics and investigate tumor-cell response. This perspective connects its mechanism and model-specific evidence to practical study design, while distinguishing useful hypotheses from conclusions the data do not yet support.
-
Synthetic Receptor Microglia for Amyloid-β Clearance
2026-09-27
A 2025 mouse study reports a synthetic efferocytic receptor that reprograms microglia to recognize and clear amyloid-β while limiting inflammatory signaling. The work combines an amyloid-targeting binding domain with efferocytosis-associated signaling and microglia-directed mRNA delivery, offering a distinct preclinical strategy from conventional antibody-mediated clearance.
-
Cy5-UTP for RNA Probes: Workflow & Troubleshooting
2026-09-26
Use Cy5-UTP to make fluorescent RNA probes for FISH and related assays, with a practical workflow for balancing signal against transcription yield. The guide also shows how to apply labeled probes to MALAT1-focused experiments while keeping fluorescence imaging distinct from the RNA–protein assays needed to test TDP-43 binding.
-
Cy5-labeled mRNA for Macrophage Delivery Assays
2026-09-25
Separate cellular uptake from successful translation with a dual-readout reporter in macrophage gene-delivery experiments. Pair Cy5 tracking with EGFP expression to compare formulations, while treating fluorescence as an assay signal—not proof of intact cytosolic mRNA or therapeutic efficacy.
-
Lypressin Acetate: Assays, Workflows & Troubleshooting
2026-09-25
Use Lypressin acetate to probe vasopressin-receptor signaling, antidiuretic biology, and vasoconstriction research with workflows tailored to each question. This guide separates established product specifications from proposed assay starting conditions and explains why exploratory SARS-CoV-2 RdRp findings need independent validation.
-
Necrosulfonamide and the Logic of Necroptosis
2026-09-24
A translational framework for using Necrosulfonamide to test whether MLKL-dependent membrane disruption contributes to injury—without confusing downstream pathway inhibition with proof of upstream mechanism or therapeutic efficacy.